Zim among top priority lenacapavir recipients as Gilead licenses Hetero
By Kuda Pembere With Zimbabwe being among the 18 top-priority recipients of lenacapavir an HIV preventive drug pending local medicines regulatory approvals, Gilead Sciences, the principal maker has granted a non-exclusive license to leading India headquartered pharmaceutical manufacturer Hetero Group of Companies to manufacture and supply the drug. Gilead’s decision comes following much advocacy by
Read MoreAVAC Facilitates Translation of Health and Scientific Terms Into 10 African Languages
By Michael Gwarisa In a bid to bridge information gaps between scientific research and community understanding, AVAC has launched the Translation Index, a translation of health and scientific terms into vernacular languages for Six African countries. The Translation Index offers health journalists accurate translations of commonly used and essential medical terms in their native languages
Read MoreGovernments should take ownership of VMMC programs says AVAC
By Michael Gwarisa To ensure the sustainability of Voluntary Medical Male Circumcision (VMMC) programs in the face of dwindling donor support and donor fatigue, African governments have been urged to fund and promote VMMC programs. Since VMMC was recommended by WHO and the UNAIDS in 2007 as key to HIV prevention in high prevalence settings,
Read More